[show abstract][hide abstract] ABSTRACT: M EN IN THE UNITED STATES have a 1 in 6 lifetime prevalence of prostate cancer. 1 Although sur-vival is excellent, urinary inconti-nence is a significant morbidity follow-ing radical prostatectomy, 1-4 often the treatment of choice for localized pros-tate cancer. Patient surveys indicate that as many as 65% of men continue to ex-perience incontinence up to 5 years af-ter surgery. 2 Loss of bladder control can be a physical, emotional, psychoso-cial, and economic burden for men who experience it. 2,4 Postprostatectomy incontinence has been attributed to intrinsic sphincter de-ficiency and/or detrusor dysfunction, leading to stress and/or urgency incon-tinence, respectively. 3 Surgical inter-ventions for incontinence are quite ef-fective 5-7 but are usually reserved for moderate to severe incontinence, and many prostate cancer survivors are re-luctant to undergo another surgery. Several randomized trials have exam-ined the effectiveness of perioperative pelvic floor muscle training and shown For editorial comment see p 197.